RZLT Chart
See on advanced chart >
About
Rezolute, Inc. was incorporated in Delaware in 2010. The company is a clinical-stage biopharmaceutical company developing therapies for metabolic diseases related to chronic glucose imbalance. The company lead clinical asset, RZ358, is a potential treatment...
Read More
- HighlightA clinical-stage biopharmaceutical company that develops drug therapies for the treatment of metabolic diseaes
- ExchangeNASDAQ
- Listing Date11/09/2020
- Established DateInvalid Date
- Full-time Employees51
- Address275 Shoreline Drive Suite 500 Redwood City California 94065
- Tel1-650-2064507
- Website
- Fiscal Year End Date06/30
- Security TypeCommon Stock
Industry
Pharmaceuticals